Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Covidien endotracheal tube helps prevent pneumonia

This article was originally published in The Gray Sheet

Executive Summary

Covidien says its Mallinckrodt SealGuard Evac entdotracheal tube, launched Feb. 2 at the Society of Critical Care Medicine Congress in Nashville, is designed to reduce microaspiration of secretions into the lungs by 95% compared with products currently on the market with high-volume, low-pressure cuffs. The device also helps provide secretion drainage through an integrated suction lumen. Last fall, the company announced plans to target high-growth market segments in the respiratory care business, including devices to fight ventilator-associated pneumonia (1"The Gray Sheet" Sept. 15, 2008, p. 13). The product received 510(k) clearance on Oct. 2, 2008

You may also be interested in...



Covidien Aims To Breathe Life Into Respiratory Biz With Ventilation Pipeline

Covidien plans to reinvigorate its respiratory business by targeting higher-growth market segments, such as devices to combat ventilator-associated pneumonia, the company said during its Sept. 10 investor day in New York

QUOTED. 22 January 2020. Steve Niedelman.

Steve Niedelman of the law firm King & Spalding gave manufacturers a few words of advice when prepping their so-called front rooms, where US FDA investigators do the majority of their work during facility inspections. See what he said here.

FDA’s Follow-Up Sunscreen Trial Shows More Of The Same: Absorption Of All Tested UV Filters

The FDA emphasizes that findings from its second, more extensive clinical study on the absorption potential of sunscreen active ingredients are not in themselves signals that the UV filters are unsafe. However, they portend heavy work ahead for industry if the ingredients are to remain GRASE and available for use in OTC sunscreen drug products stateside.  
 

Topics

UsernamePublicRestriction

Register

MT027076

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel